top of page

SPRAVATO NASAL SPRAY 28MG/VIAL

Product details

Registration number: SIN16033P

Classification: Prescription Only

Active ingredients: Esketamine HCl 32.2mg eqv. to Esketamine

Strength: 28mg/vial

Dosage form: SPRAY

Route: NASAL

Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

ATC code: N06AX27

HSA approval date: 27 October 2020

Manufacturer(s): Renaissance Lakewood LLC

Manufacturing country/countries: UNITED STATES

What are the HSA registration number and classification for SPRAVATO NASAL SPRAY 28MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16033P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for SPRAVATO NASAL SPRAY 28MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Esketamine HCl 32.2mg eqv. to Esketamine

Strength: 28mg/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for SPRAVATO NASAL SPRAY 28MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Dosage form: SPRAY

Route: NASAL

Source for this answer

Who is the recorded registrant for SPRAVATO NASAL SPRAY 28MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for SPRAVATO NASAL SPRAY 28MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Renaissance Lakewood LLC

Manufacturing country/countries: UNITED STATES

Source for this answer

Where can I look up SPRAVATO NASAL SPRAY 28MG/VIAL in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16033P or the exact product name SPRAVATO NASAL SPRAY 28MG/VIAL. The general register link does not preselect this product.

Source for this answer

What are the source dates for this SPRAVATO NASAL SPRAY 28MG/VIAL record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this SPRAVATO NASAL SPRAY 28MG/VIAL record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16033P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page